School of Medicine and Public Health, University of Newcastle, Callaghan, Australia; Department of Neurology, John Hunter Hospital, New Lambton Heights, Australia; Hunter Medical Research Institute, New Lambton, NSW, Australia.
MSSN John Hunter Hospital, Hunter New England Health, Australia.
Mult Scler Relat Disord. 2023 Nov;79:104952. doi: 10.1016/j.msard.2023.104952. Epub 2023 Aug 25.
Cognitive impairment in multiple sclerosis (MS) affects approximately 40-70% of patients and can have varying degrees of severity. Even mild cognitive impairment can impact on quality of life and productivity. Despite this, patients are not routinely screened or monitored for cognitive impairment in Australia due to a range of issues, with time and space being the main limiting factors. This Australian multidisciplinary perspective provides recommendations on cognition management in Australia. It gives a broad overview of cognition in MS, advice on the screening and monitoring tools available to clinicians, and strategies that can be implemented in clinics to help monitor for cognitive impairment in patients with MS. We suggest a routine baseline assessment and multidomain cognitive battery in regular intervals; a change should trigger a thorough investigation of the cause.
多发性硬化症（MS）患者中约有 40-70%存在认知障碍，且严重程度不一。即使是轻度认知障碍也会影响生活质量和生产力。尽管如此，由于多种因素，包括时间和空间限制，澳大利亚的患者通常不会接受认知障碍的常规筛查或监测。本澳大利亚多学科视角提供了关于澳大利亚认知障碍管理的建议。它广泛概述了多发性硬化症患者的认知情况，为临床医生提供了可用的筛查和监测工具的建议，并提出了可以在诊所实施的策略，以帮助监测多发性硬化症患者的认知障碍。我们建议在常规间隔进行常规基线评估和多领域认知测试；一旦发生变化，应彻底调查原因。
